33 results match your criteria: "Northwestern Medical Center[Affiliation]"

Background: Studies have suggested a synergism between lenalidomide (LEN) and ibrutinib (IBR) in multiple myeloma (MM). Both downregulate IRF4, a key target and master transcriptional factor regulating myeloma cell survival.

Method: A 3 + 3 phase I trial was conducted to determine the maximum tolerated dose (MTD) of IBR in combination with LEN + dexamethasone (DEX) in patients with relapsed/refractory (RR) MM who had at least one prior line of therapy.

View Article and Find Full Text PDF

Introduction: Parastomal hernia recurrence is common but poorly defined. We aimed to correlate radiographic recurrence and reoperation for parastomal hernia recurrence with patient-reported outcomes (PROs) to determine the clinical significance of radiographic recurrence and identify potential screening tools.

Methods: Patient data in the one- and two-year follow-up windows of a registry-embedded randomized controlled trial comparing open retromuscular Sugarbaker and keyhole mesh parastomal hernia repairs (2019-2022) were analyzed.

View Article and Find Full Text PDF

Damage control thoracotomy trends, techniques, and outcomes: An EAST multicenter trial.

J Trauma Acute Care Surg

September 2025

From the Department of Surgery (A.D.D., N.B., J.Finch., H.S., M.J.L.), Indiana University School of Medicine, Indianapolis, Indiana; Department of Surgery (T.Puzio), University of Texas Houston, Houston, Texas; Department of Surgery (P.M., J.Figueroa), Medical College of Wisconsin, Milwaukee, Wiscon

Background: Damage-control thoracotomy (DCT) lacks evidence regarding frequency of use, optimal technique, and outcomes. This Eastern Association for the Surgery of Trauma multicenter trial aimed to examine DCT usage over the last decade, evaluate types of temporary closure, and assess associated outcomes.

Methods: An international retrospective cohort study of thoracotomies from 2008 to 2020 at 25 centers was performed.

View Article and Find Full Text PDF

Background: The association, if any, between the transmitral mean pressure gradient (TMPG) after mitral transcatheter edge-to-edge repair and 1-year mortality is controversial in patients undergoing mitral transcatheter edge-to-edge repair with the MitraClip system. We sought to estimate the association between intraoperatively measured residual mitral regurgitation (rMR) and TMPG and 1-year mortality among patients undergoing mitral transcatheter edge-to-edge repair to facilitate decisions on additional devices.

Methods: In patients with severe secondary (functional) MR, we analyzed registry data using generalized estimating equations.

View Article and Find Full Text PDF

CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.

Radiology

November 2024

From the Department of Radiology, University of Michigan Health System, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5030 (A.A., M.M.L.); Department of Radiology, Memorial Sloan Kettering Medical Center, New York, NY (V.C., R.D., H.Y.); Department of Radiology, Northwestern Medical Center, Chicago,

With the rising incidence of hepatocellular carcinoma, there has been increasing use of local-regional therapy (LRT) to downstage or bridge to transplant, for definitive treatment, and for palliation. The CT/MRI Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Assessment (TRA) algorithm provides guidance for step-by-step tumor assessment after LRT and standardized reporting. Current evidence suggests that the algorithm performs well in the assessment of tumor response to arterial embolic and loco-ablative therapies and fair when assessing response to radiation-based therapies, with limited data to validate the latter.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the link between effective regurgitant orifice area (EROA) to left ventricular end-diastolic volume (LVEDV) ratio and 1-year mortality in patients treated with the MitraClip system for severe secondary mitral regurgitation.
  • Analysis of data from 525 patients showed that lower EROA/LVEDV values were linked to higher mortality rates, with a 1-year mortality rate of 22%.
  • The findings suggest that a lower logarithmic transformation of EROA/LVEDV correlates with increased risk of death, indicating that this ratio could be a potential prognostic marker in post-m-TEER patients.
View Article and Find Full Text PDF

Vagus Nerve Stimulation (VNS) therapy is widely understood to provide clinically meaningful improvements in seizure control to patients with drug-resistant epilepsy, and has been a staple in the clinical armamentaria available to epileptologists for over 25 years. Despite the long history of evidence-based reviews by neurology professional societies, there is still evidence of a practice gap in VNS titration and dosing that aims to maximize clinical benefit. Recent retrospective analyses have strongly argued for a more consistent application of a population-wide target dose of VNS, and further argued the importance of quickly achieving this target dose to hasten the onset of clinical benefits; however, these analyses failed to provide evidence for practical implementation.

View Article and Find Full Text PDF

Introduction: Since the 1999 Institute of Medicine report, hospitals have implemented a myriad of measures to protect patients from medical errors. At this point, looking beyond errors may bring additional safety benefits. This study aims to analyze predictors of in-hospital death regardless of underlying diagnoses in an effort to identify additional targets for improvement.

View Article and Find Full Text PDF

Background And Aims: Visible lesion (VL) detection is essential in patients with Barrett's esophagus (BE). We sought to assess the rate of VL detection by academic and community endoscopists using high-definition white-light endoscopy (HD-WLE) and narrow-band imaging (NBI) during surveillance endoscopy.

Methods: Fifty endoscopists were invited to participate in a prospective video survey study.

View Article and Find Full Text PDF

Scleral Plaques in Nephrogenic Systemic Fibrosis.

Cutis

January 2022

Division of Dermatology, University of California Los Angeles. Dr. Dreyer currently is from the Department of Physical Medicine and Rehabilitation, Northwestern Medical Center, Chicago, Illinois. Dr. Rodriguez currently is from Health Partners Park Nicollet, Burnsville, Minnesota. Dr. Worswick curre

View Article and Find Full Text PDF

Congenital and Perinatal Tuberculosis.

Neoreviews

September 2021

Division of Pediatric Infectious Disease, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern Medical Center, Chicago, IL.

This review discusses the recent literature (2006-2020) about the epidemiology, clinical presentation, diagnosis, and management of infants with congenital or perinatal tuberculosis (TB). While the incidence of childhood TB is declining in the United States and worldwide, many case reports describe how clinical suspicion for neonatal TB is raised only if an ill-appearing neonate does not improve with broad-spectrum antibiotics. Furthermore, the delay in initiating appropriate anti-TB therapy often results in the need for significant cardiopulmonary support and/or an increase in mortality.

View Article and Find Full Text PDF

Introduction Hyperglycemia and hypoglycemia have been found to increase morbidity and mortality among hospitalized patients with diabetes. In July of 2018, our academic medical center experienced a 48-hour nursing strike, during which time 600 replacement nurses were employed. This cohort study evaluated the impact of the nursing strike on glycemic control among hospitalized patients with diabetes.

View Article and Find Full Text PDF

BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).

View Article and Find Full Text PDF

The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards.

Oncologist

September 2021

Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care, Madison, Wisconsin, USA.

Background: The proportion of women in the field of hematology and oncology (H&O) has increased over recent decades, but the representation of women in leadership positions remains poor. In an effort to close the gender gap in academia, it is important to report on such inequities in hopes to close these gaps and improve career development.

Materials And Methods: We conducted a retrospective, observational study of published award recipients from 1994 to 2019 from the seven major H&O societies in the world.

View Article and Find Full Text PDF

Objective: To objectively determine the prevalence of overweight and obesity in elementary school children in two rural counties in Vermont prior to implementing a community-based intervention.

Methods: School-based objective measures of body mass index (BMI) were obtained from 1,688 public school children in first, third, and fifth grades in two Northern Vermont counties in the Fall of 2017.

Results: Forty-one percentage of elementary school children were either overweight or obese, nearly double the estimated Vermont prevalence rate of 22.

View Article and Find Full Text PDF

Randomized controlled trials can provide optimal clinical evidence to assess the benefits of new devices, and it is these data that often shape device usage in real-world practice. However, individual clinical trial results sometimes appear discordant for the same device, and alternative devices are sometimes not employed in similar patient populations. To make sound evidence-based decisions, clinicians routinely rely on cross-trial comparisons from different trials of similar but not identical patient populations to assess competing technology when head-to-head randomized comparisons are unavailable.

View Article and Find Full Text PDF

in Lung Cancers: Analysis of Patient Cases Reveals Recurrent Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.

JCO Precis Oncol

April 2018

, Vancouver General Hospital, Vancouver, British Columbia, Canada; , , , , , , , , , , , , , , , , , , and , Foundation Medicine, Cambridge, MA; , The Angeles Clinic and Research Institute and Cedars-Sinai Medical Center, Los Angeles; , University ofCalifornia San Diego, San Diego; , University of

Purpose: Dabrafenib and trametinib are approved for the management of advanced non-small-cell lung cancers (NSCLCs) that harbor V600E mutations. Small series and pan-cancer analyses have identified non-V600 alterations as therapeutic targets. We sought to examine a large genomic data set to comprehensively characterize non-V600 B alterations in lung cancer.

View Article and Find Full Text PDF

Background: This study determined the feasibility and potential efficacy of an evidence-based standardized smoking cessation intervention delivered by vascular surgeons to smokers with peripheral arterial disease.

Methods: We performed a cluster-randomized trial of current adult smokers referred to eight vascular surgery practices from September 1, 2014, to July 31, 2015. A three-component smoking cessation intervention (physician advice, nicotine replacement therapy, and telephone-based quitline referral) was compared with usual care.

View Article and Find Full Text PDF

OBJECTIVE The authors performed a study to identify clinical characteristics of pediatric patients diagnosed with Chiari I malformation and scoliosis associated with a need for spinal fusion after posterior fossa decompression when managing the scoliotic curve. METHODS The authors conducted a multicenter retrospective review of 44 patients, aged 18 years or younger, diagnosed with Chiari I malformation and scoliosis who underwent posterior fossa decompression from 2000 to 2010. The outcome of interest was the need for spinal fusion after decompression.

View Article and Find Full Text PDF

Objectives: This study compares the functional outcomes of nevus intermedius impairment following surgery, radiation, or observation for the treatment of vestibular schwannoma.

Study Design: Retrospective cohort study.

Settings: Tertiary care medical center.

View Article and Find Full Text PDF

Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization.

J Clin Endocrinol Metab

May 2016

Departments of Public Health Sciences (S.N.Y., H.K., A.L., R.H., L.D., R.C., R.D.-A.) and Medicine (H.K.), Division of Nephrology and Hypertension, and Division of Endocrinology (P.C.), Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153; Institute of Social and Preventive

Context: Compensatory increases in fibroblast growth factor 23 (FGF23) with increasing phosphate intake may adversely impact health. However, population and clinical studies examining the link between phosphate intake and FGF23 levels have focused mainly on populations living in highly industrialized societies in which phosphate exposure may be homogenous.

Objective: The objective of the study was to contrast dietary phosphate intake, urinary measures of phosphate excretion, and FGF23 levels across populations that differ by the level of industrialization.

View Article and Find Full Text PDF

Using a Learning Collaborative Strategy With Office-based Practices to Increase Access and Improve Quality of Care for Patients With Opioid Use Disorders.

J Addict Med

December 2016

Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire (BRN); Dartmouth Psychiatric Research Center, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire (ECS, BM); Department of Psychiatry, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire (AM, CL-

Objectives: Rapidly escalating rates of heroin and prescription opioid use have been widely observed in rural areas across the United States. Although US Food and Drug Administration-approved medications for opioid use disorders exist, they are not routinely accessible to patients. One medication, buprenorphine, can be prescribed by waivered physicians in office-based practice settings, but practice patterns vary widely.

View Article and Find Full Text PDF